Stockreport

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

CYTODYN INC  (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
PDF Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United States VANCOUVER, Washington, April 21, 2026 ( [Read more]